Pfizer Inc. (PFE)

NYSE - NYSE Real Time Price. Currency in USD
35.11+0.29 (+0.83%)
At close: 4:00 PM EDT

35.11 0.00 (0.00%)
Pre-Market: 8:00 AM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close34.82
Bid34.90 x 100
Ask35.20 x 800
Day's Range34.81 - 35.17
52wk Range28.25 - 37.39
1y Target EstN/A
Market Cap212.96B
P/E Ratio (ttm)31.13
Avg Vol (3m)21,923,770
Dividend & Yield1.20 (3.45%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Motley Fool16 minutes ago

    What's Up With Mylan's EpiPen Pricing?

    An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation shares this week.

  • Mylan To Launch Its Own EpiPen Generic Rival At Half Price
    Investor's Business Daily16 hours ago

    Mylan To Launch Its Own EpiPen Generic Rival At Half Price

    Bowing to political pressure, Mylan's generics arm will sell a cut-rate version of its own best-selling product.

  • Market Realist18 hours ago

    Analyst Recommendations for Akorn in 2016

    Analyst recommendations from 17 brokerage firms surveyed by Bloomberg for Akorn (AKRX), 62.5% gave it a “buy,” 37.5% gave it a “hold,” and none gave it a “sell.”